Molecular imaging developer Bioscan of Washington, DC, is launching NanoSPECT/CTPlus, a new in vivo SPECT system for preclinical imaging, at this week's SNM meeting in Salt Lake City.
NanoSPECT/CTPlus includes a number of enhancements over the company's older NanoSPECT/CT technology, including rotational, helical, and stationary SPECT scanning and real-time CT reconstruction based on graphics processing unit (GPU) technology.
Other features include new updates in multipinhole SPECT imaging technology, computer hardware, and image reconstruction and processing software. NanoSPECT/CTPlus is designed to enable researchers to conduct longitudinal studies on a range of models including the mouse, rat, rabbit, and nonhuman primates.
In NanoSPECT/CT news, Bioscan is touting results of a study in which a multicenter group of 13 researchers from the U.K. and Spain used the system to study functionalized sealed carbon nanotubes filled with a radionuclide without prompting cargo release. The study was published in the May 2010 issue of Nature Materials.
In other news, Bioscan announced that it has begun shipments in Europe and North America of its preclinical PET system, NanoPET/CT. Also designed for animal imaging, the scanner was first introduced as a work-in-progress at the 2009 SNM show.
Finally, Bioscan is promoting its development of new radiochemistry products for the radiosynthesis of PET compounds without the use of high-performance liquid chromatography (HPLC). The company believes the products will accelerate the U.S. Food and Drug Administration (FDA) approval process for these tracers.
Related Reading
Philips, Bioscan partner on NanoSPECT marketing, January 2, 2007
Bioscan licenses IDSI molecular imaging technology, September 5, 2006
Bioscan displays NanoSPECT/CT animal imager, June 7, 2006
Copyright © 2010 AuntMinnie.com
